Alcon

Yahoo Finance • 12 months ago

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

Lifecore Biomedical, Inc. Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore receives amendment and waiver for its term debt facility with Alcon and BMO CHASKA, M... Full story

Yahoo Finance • last year

Alcon Reports Third Quarter 2023 Results

Third quarter 2023 sales of $2.3 billion, up 8%, or 9% constant currency(1) (cc) Third quarter 2023 diluted EPS of $0.41, up 78%, or up 97% cc; core diluted EPS(2) of $0.66 up 32%, or 41% cc Generated $937 million of cash from operating ac... Full story

Yahoo Finance • last year

Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia

The first and only monthly Water Gradient multifocal contact lens — feels like nothing even at day 301 Provides excellent visual acuity at all distances, near through far, with Alcon’s proven Precision Profile design that fits in two easy... Full story

Yahoo Finance • last year

12 Best Pharma ETFs

In this article, we discuss the 12 best pharma ETFs. If you want to skip our discussion on the pharma industry, you can go directly to the 5 Best Pharma ETFs. As of 2023, Deloitte has valued the pharmaceutical, biotechnology, and medical... Full story

Yahoo Finance • last year

12 Best Healthcare ETFs To Buy

In this article, we discuss 12 best healthcare ETFs. If you want to skip our discussion on the healthcare market, head directly to 5 Best Healthcare ETFs To Buy. In December 2022, BlackRock highlighted concerns about the performance for t... Full story

Yahoo Finance • last year

Alcon Inc. (NYSE:ALC) Q2 2023 Earnings Call Transcript

Alcon Inc. (NYSE:ALC) Q2 2023 Earnings Call Transcript August 16, 2023 Operator: Greetings, welcome to Alcon's Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will... Full story

Yahoo Finance • 2 years ago

15 Largest Ophthalmology Companies in the World

In this article, we will take a look at the 15 largest ophthalmology companies in the world. If you want to see more companies in this selection, go to the 5 Largest Ophthalmology Companies in the World. The ophthalmology industry encompa... Full story

Yahoo Finance • 2 years ago

Alcon Prices US$1.3 Billion Senior Notes Offering

GENEVA, November 30, 2022--(BUSINESS WIRE)--Alcon Inc. ("Alcon") (SIX/NYSE: ALC) announced that it has commenced and priced a private offering of US$700 million aggregate principal amount of its 5.375% senior notes due 2032 and US$600 mill... Full story

Yahoo Finance • 2 years ago

Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

Leveraging Alcon’s robust commercial capabilities and resources to drive further growth and access to Rocklatan and Rhopressa Acquisition adds pharmaceutical research and development capabilities and further expertise for future product pi... Full story

Yahoo Finance • 2 years ago

Alcon Reports Third Quarter 2022 Results

Third quarter 2022 sales of $2.1 billion, up 2%, or 9% constant currency (cc) Third quarter 2022 earnings were $0.23 per diluted share; core earnings of $0.50 per diluted share, down 7%, or up 14% cc Updated 2022 outlook reflects strong sa... Full story

Yahoo Finance • 2 years ago

Top 10 Stock Picks of Roberto Mignone’s Bridger Management

In this article, we discuss the top 10 stock picks of Roberto Mignone's Bridger Management. If you want to skip our detailed analysis of Mignone's history, investment philosophy, and hedge fund performance, go directly to Top 5 Stock Picks... Full story

Yahoo Finance • 3 years ago

Alcon Reports First Quarter 2022 Results

Strong quarterly sales of $2.2 billion, up 14% or 18% constant currency Double-digit growth in net sales in both Surgical and Vision Care Updated 2022 full year outlook Ad Hoc Announcement Pursuant to Art. 53 LR GENEVA, May 10, 2022--(BU... Full story